View Printer-Friendly PDF

A Drug Development & Outsourcing Profile

Aspect Biosystems Ltd.

1781 West 75th Avenue
Vancouver BC  V6P 6P2
Canada

  • Tel: 604-263-0502
  • CEO: Mr. Tamer Mohamed
  • Mktg: Ms. Natalie Korenic
  • CSO: Mr. Sam Wadsworth
  • Licng:
  • Est: 2013 - Private
  • Rev: $ M
  • Staff: 10–50
  • Therapeutics-Human
  • Drug Development
  • Biomaterials
  • Tissue Regeneration
  • Tech Solut'ns

Aspect Biosystems is a Canadian biotech company operating on the leading edge of 3D bioprinting and tissue engineering. Aspect has developed a disruptive 3D bioprinting platform capable of creating living human tissues. Aspect’s technology is enabling advances in fundamental biology, in drug development through novel preclinical models, and regenerative medicine where in the future, lifesaving transplant organs will be created, not harvested.

Mfg: Yes   Labs: Yes

0.0254